{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,20]],"date-time":"2026-11-20T00:08:12Z","timestamp":1795133292618,"version":"4.10.3"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinik M\u00fcnchen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Wilson disease (WD) is a rare, hereditary disorder of copper metabolism. Due to its variable symptoms and manifestations, diagnosis remains challenging. Affected patients must obtain lifelong medical treatment, as the disease is fatal if untreated. Patients require continuous monitoring, but little is known about the care of these patients in Germany. Therefore, we analyzed the medical care of WD patients at German university centers. We sent a questionnaire containing 20 questions to a total of 108 departments of pediatrics, neurology and gastroenterology in 36 university hospitals. Our questions referred to the characteristics of WD patients at the different sites and internal procedures regarding diagnosis, therapy and follow-up. A descriptive statistical analysis was performed.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixty-three departments (58%) returned our questionnaire. In total, approximately one-third of the estimated WD patients in Germany are seen annually in the outpatient clinics of these departments (approx. 950 patients). There are only a few departments which treat patients in a multidisciplinary setting (12%). Our survey revealed that for diagnosis, 51% of all departments used an algorithm based on the Leipzig score as recommended by international guidelines. Most departments apply essential parameters recommended by WD guidelines. Routine monitoring is performed at least biannually by 84% of the departments, and standard investigations for monitoring are regularly applied. A routine family screening is performed by 84% of all departments. A reduction in medical therapy during pregnancy is recommended by 46% of the departments. Only 14% suggested that WD patients should not breastfeed. Liver transplantation (LT) due to WD is a rare but repeatedly occurring event. Most departments of gastroenterology (72%) reported at least one patient with LT within the last decade.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Medical care of WD patients at German university centers follows the recommendations set forth by international guidelines, but only a few centers treat significant numbers of patients. The surveillance of patients does not follow specified standards, but most departments adhere to the accepted guidelines. The formation of central units and networks in a multidisciplinary setting should be evaluated to improve the care of WD patients.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13023-023-02731-4","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T05:01:54Z","timestamp":1684904514000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Medical care of patients with Wilson disease in Germany: a multidisciplinary survey among university centers"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3639-4964","authenticated-orcid":false,"given":"Sebastian","family":"Zimny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Bourhis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian Paul","family":"Reiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hohenester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uta","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Heinz","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Denk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"4","key":"2731_CR1","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/brain\/34.4.295","volume":"34","author":"SAK Wilson","year":"1912","unstructured":"Wilson SAK. Progressive lenticular degeneration. A familial nervous disease associated with cirrhosis of the liver. Brain. 1912;34(4):295\u2013507.","journal-title":"Brain"},{"issue":"8","key":"2731_CR2","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s00439-020-02161-3","volume":"139","author":"DF Wallace","year":"2020","unstructured":"Wallace DF, Dooley JS. ATP7B variant penetrance explains differences between genetic and clinical prevalence estimates for Wilson disease. Hum Genet. 2020;139(8):1065\u201375.","journal-title":"Hum Genet"},{"issue":"3","key":"2731_CR3","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/BF01630499","volume":"44","author":"B Fleischer","year":"1912","unstructured":"Fleischer B. \u00dcber eine der \u201cPseudosklerose\u201d nahestehende bisher unbekannte Krankheit (gekennzeichnet durch Tremor, psychische St\u00f6rungen, br\u00e4unliche Pigmentierung bestimmter Gewebe, insbesondere auch der Hornhautperipherie, Lebercirrhose). Dtsch Z Nervenheilkd. 1912;44(3):179\u2013201.","journal-title":"Dtsch Z Nervenheilkd"},{"issue":"2","key":"2731_CR4","first-page":"22","volume":"40","author":"B Kayser","year":"1902","unstructured":"Kayser B. \u00dcber einen Fall von angeborener gr\u00fcnlicher Verf\u00e4rbung des Cornea. Kin Mbl Augenheilk. 1902;40(2):22\u20135.","journal-title":"Kin Mbl Augenheilk"},{"issue":"1","key":"2731_CR5","first-page":"489","volume":"41","author":"B Fleischer","year":"1903","unstructured":"Fleischer B. Zwei weitere F\u00e4lle von gr\u00fcnlicher Verf\u00e4rbung der Kornea. Klin Monbl Augenheilkd. 1903;41(1):489\u201391.","journal-title":"Klin Monbl Augenheilkd"},{"issue":"3","key":"2731_CR6","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/00005792-199205000-00004","volume":"71","author":"GJ Brewer","year":"1992","unstructured":"Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine (Baltimore). 1992;71(3):139\u201364.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"2731_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/S0016-5085(97)70097-0","volume":"113","author":"P Steindl","year":"1997","unstructured":"Steindl P, Ferenci P, Dienes HP, Grimm G, Pabinger I, Madl C, et al. Wilson\u2019s disease in patients presenting with liver disease: a diagnostic challenge. Gastroenterology. 1997;113(1):212\u20138.","journal-title":"Gastroenterology"},{"issue":"8485","key":"2731_CR8","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/S0140-6736(86)90949-9","volume":"1","author":"JM Walshe","year":"1986","unstructured":"Walshe JM, Dixon AK. Dangers of non-compliance in Wilson\u2019s disease. Lancet. 1986;1(8485):845\u20137.","journal-title":"Lancet"},{"key":"2731_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1749-6632.2009.05109.x","volume":"1184","author":"MT Lorincz","year":"2010","unstructured":"Lorincz MT. Neurologic Wilson\u2019s disease. Ann N Y Acad Sci. 2010;1184:173\u201387.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"2731_CR10","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/BF00496571","volume":"397","author":"SM Factor","year":"1982","unstructured":"Factor SM, Cho S, Sternlieb I, Scheinberg IH, Goldfischer S. The cardiomyopathy of Wilson\u2019s disease. Myocardial alterations in nine cases. Virchows Arch A Pathol Anat Histol. 1982;397(3):301\u201311.","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"3","key":"2731_CR11","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1159\/000189114","volume":"73","author":"CC Chu","year":"1996","unstructured":"Chu CC, Huang CC, Chu NS. Recurrent hypokalemic muscle weakness as an initial manifestation of Wilson\u2019s disease. Nephron. 1996;73(3):477\u20139.","journal-title":"Nephron"},{"issue":"6","key":"2731_CR12","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1007\/BF00441555","volume":"148","author":"E Azizi","year":"1989","unstructured":"Azizi E, Eshel G, Aladjem M. Hypercalciuria and nephrolithiasis as a presenting sign in Wilson disease. Eur J Pediatr. 1989;148(6):548\u20139.","journal-title":"Eur J Pediatr"},{"issue":"6088","key":"2731_CR13","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1136\/bmj.2.6088.660","volume":"2","author":"AN Hamlyn","year":"1977","unstructured":"Hamlyn AN, Gollan JL, Douglas AP, Sherlock S. Fulminant Wilson\u2019s disease with haemolysis and renal failure: copper studies and assessment of dialysis regimens. Br Med J. 1977;2(6088):660\u20133.","journal-title":"Br Med J"},{"issue":"2","key":"2731_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/0002-9343(79)90399-1","volume":"67","author":"DO Wiebers","year":"1979","unstructured":"Wiebers DO, Wilson DM, McLeod RA, Goldstein NP. Renal stones in Wilson\u2019s disease. Am J Med. 1979;67(2):249\u201354.","journal-title":"Am J Med"},{"issue":"3","key":"2731_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0022-510X(72)90194-3","volume":"16","author":"A Czlonkowska","year":"1972","unstructured":"Czlonkowska A. A study of haemolysis in Wilson\u2019s disease. J Neurol Sci. 1972;16(3):303\u201314.","journal-title":"J Neurol Sci"},{"issue":"3","key":"2731_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.7326\/0003-4819-86-3-301","volume":"86","author":"J Roche-Sicot","year":"1977","unstructured":"Roche-Sicot J, Benhamou JP. Acute intravascular hemolysis and acute liver failure associated as a first manifestation of Wilson\u2019s disease. Ann Intern Med. 1977;86(3):301\u20133.","journal-title":"Ann Intern Med"},{"issue":"11","key":"2731_CR17","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/qjmed\/hct137","volume":"106","author":"JM Walshe","year":"2013","unstructured":"Walshe JM. The acute haemolytic syndrome in Wilson\u2019s disease: a review of 22 patients. QJM. 2013;106(11):1003\u20138.","journal-title":"QJM"},{"issue":"6","key":"2731_CR18","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1097\/00005176-198811000-00024","volume":"7","author":"Z Weizman","year":"1988","unstructured":"Weizman Z, Picard E, Barki Y, Moses S. Wilson\u2019s disease associated with pancreatitis. J Pediatr Gastroenterol Nutr. 1988;7(6):931\u20133.","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"2","key":"2731_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1179\/1743132813Y.0000000262","volume":"36","author":"LJ Lin","year":"2014","unstructured":"Lin LJ, Wang DX, Ding NN, Lin Y, Jin Y, Zheng CQ. Comprehensive analysis on clinical features of Wilson\u2019s disease: an experience over 28 years with 133 cases. Neurol Res. 2014;36(2):157\u201363.","journal-title":"Neurol Res"},{"issue":"3","key":"2731_CR20","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"EASL Clinical Practice Guidelines","year":"2012","unstructured":"EASL Clinical Practice Guidelines. Wilson\u2019s disease. J Hepatol. 2012;56(3):671\u201385.","journal-title":"J Hepatol"},{"key":"2731_CR21","doi-asserted-by":"crossref","unstructured":"Schilsky ML, Roberts EA, Bronstein JM, Dhawan A, Hamilton JP, Rivard AM, et al. A Multidisciplinary Approach to the Diagnosis and Management of Wilson Disease: 2022 Practice Guidance on Wilson Disease from the American Association for the Study of Liver Diseases. Hepatology (Baltimore, Md). 2022.","DOI":"10.1002\/hep.32801"},{"key":"2731_CR22","unstructured":"Scheinberg IH, Sternlieb I. Wilson's disease. Sternlieb I, editor. Philadelphia: Saunders; 1984."},{"issue":"2","key":"2731_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.30911","volume":"71","author":"TD Sandahl","year":"2020","unstructured":"Sandahl TD, Laursen TL, Munk DE, Vilstrup H, Weiss KH, Ott P. The prevalence of Wilson\u2019s disease: an update. Hepatology (Baltimore, MD). 2020;71(2):722\u201332.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"6","key":"2731_CR24","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1002\/hep.22261","volume":"47","author":"EA Roberts","year":"2008","unstructured":"Roberts EA, Schilsky ML. Diagnosis and treatment of Wilson disease: an update. Hepatology (Baltimore, MD). 2008;47(6):2089\u2013111.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"2","key":"2731_CR25","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/MPG.0000000000001787","volume":"66","author":"P Socha","year":"2018","unstructured":"Socha P, Janczyk W, Dhawan A, Baumann U, D\u2019Antiga L, Tanner S, et al. Wilson\u2019s disease in children: a position paper by the hepatology committee of the European Society for paediatric gastroenterology, hepatology and nutrition. J Pediatr Gastroenterol Nutr. 2018;66(2):334\u201344.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2731_CR26","doi-asserted-by":"publisher","unstructured":"Ackermann H, Arendt G, Baron R, Steinmetz H, Berlit P-D, Bien C, et al. Leitlinien f\u00fcr Diagnostik und Therapie in der Neurologie. Stuttgart: Georg Thieme Verlag; 2012. Available from: https:\/\/doi.org\/10.1055\/b-002-37755.","DOI":"10.1055\/b-002-37755"},{"issue":"6","key":"2731_CR27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1055\/s-0034-1399180","volume":"53","author":"J Weiss","year":"2015","unstructured":"Weiss J, Rau M, Bantel H, Bock H, Demir M, Kluwe J, et al. First data concerning the medical supply of patients with non-alcoholic fatty liver disease in Germany: a survey in university hospital centers of hepatology. Z Gastroenterol. 2015;53(6):562\u20137.","journal-title":"Z Gastroenterol"},{"issue":"3","key":"2731_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1034\/j.1600-0676.2003.00824.x","volume":"23","author":"P Ferenci","year":"2003","unstructured":"Ferenci P, Caca K, Loudianos G, Mieli-Vergani G, Tanner S, Sternlieb I, et al. Diagnosis and phenotypic classification of Wilson disease. Liver Int. 2003;23(3):139\u201342.","journal-title":"Liver Int"},{"issue":"9","key":"2731_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.7326\/0003-4819-115-9-720","volume":"115","author":"W Stremmel","year":"1991","unstructured":"Stremmel W, Meyerrose KW, Niederau C, Hefter H, Kreuzpaintner G, Strohmeyer G. Wilson disease: clinical presentation, treatment, and survival. Ann Intern Med. 1991;115(9):720\u20136.","journal-title":"Ann Intern Med"},{"issue":"2","key":"2731_CR30","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/jimd.12046","volume":"42","author":"J Pfeiffenberger","year":"2019","unstructured":"Pfeiffenberger J, Lohse CM, Gotthardt D, Rupp C, Weiler M, Teufel U, et al. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. J Inherit Metab Dis. 2019;42(2):371\u201380.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"2731_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1097\/MD.0b013e318045a00e","volume":"86","author":"AB Taly","year":"2007","unstructured":"Taly AB, Meenakshi-Sundaram S, Sinha S, Swamy HS, Arunodaya GR. Wilson disease: description of 282 patients evaluated over 3 decades. Medicine (Baltimore). 2007;86(2):112\u201321.","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"2731_CR32","first-page":"71","volume":"16","author":"AA Asadi Pooya","year":"2005","unstructured":"Asadi Pooya AA, Eslami NS, Haghighat M. Wilson disease in southern Iran. Turk J Gastroenterol. 2005;16(2):71\u20134.","journal-title":"Turk J Gastroenterol"},{"issue":"1","key":"2731_CR33","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1136\/gut.2005.087262","volume":"56","author":"U Merle","year":"2007","unstructured":"Merle U, Schaefer M, Ferenci P, Stremmel W. Clinical presentation, diagnosis and long-term outcome of Wilson\u2019s disease: a cohort study. Gut. 2007;56(1):115\u201320.","journal-title":"Gut"},{"issue":"Suppl 2","key":"2731_CR34","doi-asserted-by":"publisher","first-page":"S70","DOI":"10.21037\/atm.2019.03.02","volume":"7","author":"F Woimant","year":"2019","unstructured":"Woimant F, Djebrani-Oussedik N, Poujois A. New tools for Wilson\u2019s disease diagnosis: exchangeable copper fraction. Ann Transl Med. 2019;7(Suppl 2):S70.","journal-title":"Ann Transl Med"},{"key":"2731_CR35","unstructured":"Danks D. Disorders of copper transport, in (Scriver, CR; Beaudet, AL; Sly, WM; Valle, D.) The Metabolic and Molecular Basis of Inherited Disease. McGraw-Hill, Editor; 1995."},{"issue":"5","key":"2731_CR36","doi-asserted-by":"publisher","first-page":"1477","DOI":"10.1007\/s00216-009-2809-6","volume":"394","author":"S El Balkhi","year":"2009","unstructured":"El Balkhi S, Poupon J, Trocello JM, Leyendecker A, Massicot F, Galliot-Guilley M, et al. Determination of ultrafiltrable and exchangeable copper in plasma: stability and reference values in healthy subjects. Anal Bioanal Chem. 2009;394(5):1477\u201384.","journal-title":"Anal Bioanal Chem"},{"issue":"23\u201324","key":"2731_CR37","doi-asserted-by":"publisher","first-page":"2254","DOI":"10.1016\/j.cca.2011.08.019","volume":"412","author":"S El Balkhi","year":"2011","unstructured":"El Balkhi S, Trocello JM, Poupon J, Chappuis P, Massicot F, Girardot-Tinant N, et al. Relative exchangeable copper: a new highly sensitive and highly specific biomarker for Wilson\u2019s disease diagnosis. Clin Chim Acta. 2011;412(23\u201324):2254\u201360.","journal-title":"Clin Chim Acta"},{"issue":"8102","key":"2731_CR38","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1016\/S0140-6736(78)92141-4","volume":"2","author":"TU Hoogenraad","year":"1978","unstructured":"Hoogenraad TU, Van den Hamer CJ, Koevoet R, Korver EG. Oral zinc in Wilson\u2019s disease. Lancet. 1978;2(8102):1262.","journal-title":"Lancet"},{"issue":"2\u20133","key":"2731_CR39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/0022-510X(87)90116-X","volume":"77","author":"TU Hoogenraad","year":"1987","unstructured":"Hoogenraad TU, Van Hattum J, Van den Hamer CJ. Management of Wilson\u2019s disease with zinc sulphate Experience in a series of 27 patients. J Neurol Sci. 1987;77(2\u20133):137\u201346.","journal-title":"J Neurol Sci"},{"issue":"4","key":"2731_CR40","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1053\/j.gastro.2010.12.034","volume":"140","author":"KH Weiss","year":"2011","unstructured":"Weiss KH, Gotthardt DN, Klemm D, Merle U, Ferenci-Foerster D, Schaefer M, et al. Zinc monotherapy is not as effective as chelating agents in treatment of Wilson disease. Gastroenterology. 2011;140(4):1189-98.e1.","journal-title":"Gastroenterology"},{"key":"2731_CR41","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1750-1172-9-41","volume":"9","author":"G Ranucci","year":"2014","unstructured":"Ranucci G, Di Dato F, Spagnuolo MI, Vajro P, Iorio R. Zinc monotherapy is effective in Wilson\u2019s disease patients with mild liver disease diagnosed in childhood: a retrospective study. Orphanet J Rare Dis. 2014;9:41.","journal-title":"Orphanet J Rare Dis"},{"issue":"5","key":"2731_CR42","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1001\/archneur.1987.00520170020016","volume":"44","author":"GJ Brewer","year":"1987","unstructured":"Brewer GJ, Terry CA, Aisen AM, Hill GM. Worsening of neurologic syndrome in patients with Wilson\u2019s disease with initial penicillamine therapy. Arch Neurol. 1987;44(5):490\u20133.","journal-title":"Arch Neurol"},{"issue":"4","key":"2731_CR43","first-page":"264","volume":"30","author":"K Dzie\u017cyc","year":"2015","unstructured":"Dzie\u017cyc K, Litwin T, Chabik G, Cz\u0142onkowska A. Measurement of urinary copper excretion after 48-h d-penicillamine cessation as a compliance assessment in Wilson\u2019s disease. Funct Neurol. 2015;30(4):264\u20138.","journal-title":"Funct Neurol"},{"issue":"1","key":"2731_CR44","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/BF02779512","volume":"26","author":"N Shimono","year":"1991","unstructured":"Shimono N, Ishibashi H, Ikematsu H, Kudo J, Shirahama M, Inaba S, et al. Fulminant hepatic failure during perinatal period in a pregnant woman with Wilson\u2019s disease. Gastroenterol Jpn. 1991;26(1):69\u201373.","journal-title":"Gastroenterol Jpn"},{"issue":"1","key":"2731_CR45","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1186\/s12884-019-2641-8","volume":"19","author":"XE Yu","year":"2019","unstructured":"Yu XE, Pan M, Han YZ, Yang RM, Wang J, Gao S. The study of Wilson disease in pregnancy management. BMC Pregnancy Childbirth. 2019;19(1):522.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"1","key":"2731_CR46","doi-asserted-by":"publisher","first-page":"e000948","DOI":"10.1136\/bmjpo-2020-000948","volume":"5","author":"H Kodama","year":"2021","unstructured":"Kodama H, Anan Y, Izumi Y, Sato Y, Ogra Y. Copper and zinc concentrations in the breast milk of mothers undergoing treatment for Wilson\u2019s disease: a prospective study. BMJ Paediatr Open. 2021;5(1):e000948.","journal-title":"BMJ Paediatr Open"},{"issue":"12","key":"2731_CR47","first-page":"1293","volume":"31","author":"R Adam","year":"2018","unstructured":"Adam R, Karam V, Cailliez V, Grady JGO, Mirza D, Cherqui D, et al. 2018 annual report of the European Liver Transplant Registry (ELTR): 50-year evolution of liver transplantation. Transpl Int Off J Eur Soc Organ Transpl. 2018;31(12):1293\u2013317.","journal-title":"Transpl Int Off J Eur Soc Organ Transpl"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-023-02731-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-023-02731-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T06:06:20Z","timestamp":1684908380000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-023-02731-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2731"],"URL":"https:\/\/doi.org\/10.1186\/s13023-023-02731-4","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"20 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the institution\u2019s ethics committee (University Hospital, LMU Munich, Germany, Project Number 21-0813 kB).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"IM received fees for activities as speaker from Orphalan and Univar. IM received fees as a travel grant from and Univar. IM functions as a Principal Investigator in clinical trials for Alexion and Univar. HB received lecture fees and travel grants from AbbVie, Gilead and the Falk Foundation. GD received fees for activities as speaker or counselor as well as travel support from AbbVie, Alexion, Falk Foundation, Gilead, Intercept, Novartis, Orphalan and Univar. All other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}